Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Hims & Hers is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-10-07Current report (material event)
- SCHEDULE 13D/A2026-08-31SCHEDULE 13D/A
- 10-Q2026-08-10Quarterly report
- 8-K2026-08-10Current report (material event)
- SCHEDULE 13G2026-07-31SCHEDULE 13G
- SCHEDULE 13G/A2026-07-28SCHEDULE 13G/A
- 8-K2026-07-17Current report (material event)
- 8-K2026-07-01Current report (material event)
- 8-K2026-06-15Current report (material event)
- 8-K2026-06-02Current report (material event)
- 8-K2026-05-21Current report (material event)
- 8-K2026-05-19Current report (material event)
- SCHEDULE 13G2026-05-15SCHEDULE 13G
- SCHEDULE 13G/A2026-05-14SCHEDULE 13G/A
- 10-Q2026-05-11Quarterly report
- 8-K2026-05-11Current report (material event)
- ARS2026-04-28Annual report to holders
- DEFA14A2026-04-28DEFA14A
- DEF 14A2026-04-28Proxy statement
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 8-K2026-03-11Current report (material event)
- SCHEDULE 13G/A2026-03-05SCHEDULE 13G/A
- S-82026-02-24Employee stock plan
- 10-K2026-02-23Annual report
- 8-K2026-02-23Current report (material event)
- 8-K2026-02-19Current report (material event)
- SCHEDULE 13G/A2026-02-13SCHEDULE 13G/A
- 8-K2025-11-17Current report (material event)
- 10-Q2025-11-03Quarterly report
- 8-K2025-11-03Current report (material event)
- SCHEDULE 13G2025-10-31SCHEDULE 13G
- 8-K2025-10-02Current report (material event)
- 8-K2025-09-22Current report (material event)
- 8-K2025-09-05Current report (material event)
- SCHEDULE 13D/A2025-08-13SCHEDULE 13D/A
- SCHEDULE 13G2025-08-13SCHEDULE 13G
- 10-Q2025-08-04Quarterly report
- 8-K2025-08-04Current report (material event)
- 8-K2025-06-17Current report (material event)
- 8-K2025-05-13Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.